Ledger.Open graph →
SEC Form D · Amendment · filed March 2, 2018

Iterum Therapeutics Ltd

Offering
$78.1M
Sold
$78.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
DUBLIN, Ireland
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (26)

Brenton K. Ahrens · Dublin, IrelandDirectorMichael W. Dunne · Dublin, IrelandExec · PromoterRonald M. Hunt · Dublin, IrelandDirectorMark I. Chin · Dublin, IrelandDirectorCorey N. Fishman · Dublin, IrelandExec · Director · PromoterRobert I. Hopfner · Dublin, IrelandDirectorJudith M. Matthews · Dublin, IrelandExec · PromoterShahzad I. Malik · Dublin, IrelandDirectorDavid I. Kelly · Dublin, IrelandDirectorPaul R. Edick · Dublin, IrelandDirectorJames I. Healy · Dublin, IrelandDirectorJeff I. Schaffnit · Dublin, IrelandExecPatrick J. Heron · Dublin, IrelandDirectorBrenton K. Ahrens · Dublin, IrelandDirectorMichael W. Dunne · Dublin, IrelandExec · PromoterRonald M. Hunt · Dublin, IrelandDirectorMark I. Chin · Dublin, IrelandDirectorCorey N. Fishman · Dublin, IrelandExec · Director · PromoterRobert I. Hopfner · Dublin, IrelandDirectorJudith M. Matthews · Dublin, IrelandExec · PromoterShahzad I. Malik · Dublin, IrelandDirectorJeff I. Schaffnit · Dublin, IrelandExecPatrick J. Heron · Dublin, IrelandDirectorDavid I. Kelly · Dublin, IrelandDirectorPaul R. Edick · Dublin, IrelandDirectorJames I. Healy · Menlo Park, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗